Patent details

Basic Information

Publication number:

LUC00008

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP108050782

Legal Status:

Inactive

Application number:

LUC00008

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/16/1142

Marketing Authorization Type:

Marketing Authorization Date:

15/11/2016

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Luxembourg (LU)

Dates

Filing date:

09/03/2017

First Marketing Authorization date:

15/11/2016

Grant date:

30/05/2017

Activation date:

Publication date:

16/03/2017

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

15/11/2031

SPC Extension Expiration:

15/11/2031

Rejection date:

Withdrawal date:

Owner

From:

09/03/2017

 

 

Name:

Kai Pharmaceuticals Inc.

Address:

270 Littlefield Avenue, South San Francisco, CA 94080, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

09/03/2017

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Publication

Bulletin

1

Bulletin Heading:

SPC1

Bulletin edition number:

2017/02

Publication date:

22/06/2017

Description:

Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:

SPC2

Bulletin edition number:

2017/03

Publication date:

21/07/2017

Description:

Section D : Granted supplementary protection certificates – I2 publication

Annual Fees

Annual Fee Due Date:

31/07/2030

Annual Fee Number:

21

Annual Fee Amount:

410 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
16/03/2017	Publication	1
09/03/2017	Application Form	4
30/05/2017	Certificate	1
09/03/2017	General Document	36
09/03/2017	General Document	2
09/03/2017	General Document	3
30/05/2017	Publication	1